- Cervical Cancer - Download in PDF format Emzor Pharmaceuticals
Constraints
Papanicolaou (PAP) testing has resulted in dramatically lowered cervical cancer rates when the test is repeated every few years, but most developing countries lack the resources infrastructure and trainees personnel needed to implement such programs.
Effective screening programs require high coverage of women at risk, quality screening tests and effective follow-up and treatment. These are often challenging to achieve since pap tests require a doctor nurse to collect a cervical cell sample, a cytotechnician to process and interpret sample and a pathologist to confirm positive result.
